Skip to main navigation
Upstazaâ„¢ Granted Marketing Authorization by European Commission as First Disease-Modifying Treatment for AADC Deficiency
  • Sign Up for Alerts
  • Clinical Trials
  • Investors
PTC Therapeutics Facebook PTC Therapeutics LinkedIn PTC Therapeutics Twitter
Toggle Menu
  • Our Company
    • About PTC Therapeutics
      • Patient-Centric Approach
      • Responsibility
      • Global Compliance Program
    • Grants, Donations and Awards
      • STRIVE Awards Program
      • Investigator Initiated Studies (IIS)
    • Leadership
    • Contact Us
    • Locations
  • Our Science
    • Expertise
      • Alternative Splicing Programs
      • Bio-e Electron Transfer
      • Gene Therapy
      • Nonsense Readthrough
      • Transcript Regulators
    • Therapeutic Areas
  • Our Pipeline
    • Portfolio Pipeline
    • Approved Medicines
    • Clinical Trials
  • News & Resources
    • Newsroom
    • Press Releases
    • Resources for Patients
    • Resources for Health Care Professionals
  • Careers
    • Careers with Purpose
    • Fellowship
Banner

Stock Information

Stock Information

Stock Quote ()

Previous Close
Open
Volume
Exchange
Day High
Day Low
52-Week High
52-Week Low

Stock Chart

Sign up for email alerts.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Governance / Compliance
  • Financial Information
  • Annual Report and Proxy
  • Sustainability Report
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS
About PTC Therapeutics Investors Expertise Newsroom Portfolio Pipeline Careers
© 2022 PTC Therapeutics. All rights reserved.
Terms of Use